vindesine has been researched along with Hematologic Malignancies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benarfa, A; Beylot-Barry, M; Dequidt, L; Ducharme, O; Dumas, PY; Gérard, E; Pham-Ledard, A | 1 |
| Cai, HL; Dai, LB; Jiang, ZP; Li, HD; Peng, WX; Xu, P; Zhu, RH | 1 |
1 trial(s) available for vindesine and Hematologic Malignancies
| Article | Year |
|---|---|
Validated HILIC-MS/MS assay for determination of vindesine in human plasma: Application to a population pharmacokinetic study.
Topics: Adult; Antineoplastic Agents, Phytogenic; Calibration; Chromatography, High Pressure Liquid; Female; Hematologic Neoplasms; Humans; Limit of Detection; Male; Middle Aged; Reference Standards; Reproducibility of Results; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Vinblastine; Vindesine; Vinorelbine; Young Adult | 2014 |
1 other study(ies) available for vindesine and Hematologic Malignancies
| Article | Year |
|---|---|
Vindesine dexamethasone as a therapeutic option in elderly blastic plasmacytoid dendritic cell neoplasms: a monocentric experience.
Topics: Aged; Dendritic Cells; Dexamethasone; Hematologic Neoplasms; Humans; Myeloproliferative Disorders; Skin Neoplasms; Vindesine | 2021 |